Literature DB >> 16885056

An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patients.

Jean Baptiste Micol1, Stéphane de Botton, Romain Guieze, Valérie Coiteux, Stéphane Darre, Rodrigue Dessein, Olivier Leroy, Ibrahim Yakoub-Agha, Bruno Quesnel, Francis Bauters, Gilles Beaucaire, Serge Alfandari.   

Abstract

We retrospectively identified an outbreak of 18 episodes of P. aeruginosa bacteriemia in 17 patients with hematologic malignancies in 2004. All strains were ticarcillin I/R, 77% ciprofloxacin I/R, 72% ceftazidime I/R, 72% amikacin I/R and 50% imipenem I/R. The outbreak was multiclonal. Colistin was employed for documented therapy in ten cases including seven in which it was the only active drug. Outcomes were resolution of infection in 12 out of 18 episodes (67%), and death in six cases, five (25%) of which were attributable to the infection. Colistin was useful even in highly resistant strains and the efficacy of antibacterial therapy was similar (57%)in bacteriemia due to strains only susceptible to colistin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885056

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  8 in total

1.  Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.

Authors: 
Journal:  GMS Hyg Infect Control       Date:  2022-04-13

Review 2.  The prevention and management of infections due to multidrug resistant organisms in haematology patients.

Authors:  Jason A Trubiano; Leon J Worth; Karin A Thursky; Monica A Slavin
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

3.  Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis.

Authors:  Eduardo Lopez-Medina; Di Fan; Laura A Coughlin; Evi X Ho; Iain L Lamont; Cornelia Reimmann; Lora V Hooper; Andrew Y Koh
Journal:  PLoS Pathog       Date:  2015-08-27       Impact factor: 6.823

Review 4.  Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.

Authors:  Sehnaz Alp; Murat Akova
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-01-01       Impact factor: 2.576

5.  Outbreak of multi-drug resistant Pseudomonas aeruginosa bloodstream infection in the haematology unit of a South African Academic Hospital.

Authors:  Maanda Mudau; Rachael Jacobson; Nadia Minenza; Lazarus Kuonza; Vida Morris; Heather Engelbrecht; Mark P Nicol; Colleen Bamford
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

6.  A comprehensive analysis of in vitro and in vivo genetic fitness of Pseudomonas aeruginosa using high-throughput sequencing of transposon libraries.

Authors:  David Skurnik; Damien Roux; Hugues Aschard; Vincent Cattoir; Deborah Yoder-Himes; Stephen Lory; Gerald B Pier
Journal:  PLoS Pathog       Date:  2013-09-05       Impact factor: 6.823

7.  An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy.

Authors:  Marta Ciofi Degli Atti; Paola Bernaschi; Michaela Carletti; Ida Luzzi; Aurora García-Fernández; Alice Bertaina; Annamaria Sisto; Franco Locatelli; Massimiliano Raponi
Journal:  BMC Infect Dis       Date:  2014-09-10       Impact factor: 3.090

8. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02       Impact factor: 1.513

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.